Effect of Progressive Relaxation Exercıses on Dyspnea and Comfort Level in Individuals With COPD
NCT ID: NCT06459882
Last Updated: 2024-06-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
42 participants
INTERVENTIONAL
2023-01-01
2023-08-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Progressive Relaxation Exercises in COPD
NCT04559503
Progressive Muscle Relaxation and Deep Breathing Exercises
NCT05846204
The Effect of Progressive Relaxation and Breathing Exercise on Sleep Quality and Exercise Self-Efficacy in Patients With COPD
NCT05397275
Breathibg Exercises and Inhaler Trainingfor Chronic Obstructive Pulmonary Disease (COPD) Patients
NCT04739488
Effect of Breathıng Exercıse Applıed to Indıvıduals Wıth Copd on Respıratory Functıon, Dyspnea and Qualıty of Lıfe
NCT06706297
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
progressive relaxation exercises
Patients in the intervention group received 30-minute progressive relaxation exercises for 6 weeks.
progressive relaxation exercises
Patients in the intervention group received 30-minute progressive relaxation exercises for 6 weeks
control
Patients in the control group did not receive any intervention other than standard care practices.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
progressive relaxation exercises
Patients in the intervention group received 30-minute progressive relaxation exercises for 6 weeks
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Inpatient treatment in the Internal Medicine Clinic of Izmir Urla State Hospital
* Standardised Mini Mental Test score ≥24
* Dyspnea severity ≥2 according to the MMRC dyspnoea scale
* Diagnosed with Stage II and Stage III COPD according to GOLD criteria
* Functional competence to participate in progressive relaxation exercises
* Able to access and use a smartphone
* COPD patients who agreed to participate in the study.
Exclusion Criteria
* Lung disease other than COPD, physical dependence and psychiatric illness diagnosed with
* COPD patients in the acute exacerbation period.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Izmir Bakircay University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Aysegul Celik
Asst. Prof., RN, MSc, PhD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ayşegül Çelik, PhD
Role: PRINCIPAL_INVESTIGATOR
Izmir Bakircay University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Izmir Bakırcay University
Izmir, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BakircaU
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.